Drugs / ADAIR
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04232644 | May → Jul 2019 | attention deficit-hyperactivity disorder, narcolepsy | Vallon Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADAIR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04232644 ↗ |